Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physiciansâ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDHR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļDanaher Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJan 16, 2106
āļāļĩāļāļĩāđāļBlair (Rainer M)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ61000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJan 16
āļāļĩāđāļāļĒāļđāđ2200 Pennsylvania Ave NW Ste 800W
āđāļĄāļ·āļāļWASHINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ20037-1701
āđāļāļĢāļĻāļąāļāļāđ12028280850
āđāļ§āđāļāđāļāļāđhttps://www.danaher.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDHR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJan 16, 2106
āļāļĩāļāļĩāđāļBlair (Rainer M)
Mr. Steven M. Rales
Chairman of the Board
Mr. Mitchell P. Rales
Director
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Alan G. Spoon, J.D.
Independent Director
Mr. John T. Schwieters
Independent Director
Mr. Brian W. Ellis
Senior Vice President
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
Mr. Greg Milosevich
Executive Vice President
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Steven M. Rales
Chairman of the Board
Mr. Mitchell P. Rales
Director
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
Mr. Alan G. Spoon, J.D.
Independent Director
Mr. John T. Schwieters
Independent Director
Mr. Brian W. Ellis
Senior Vice President
Parnassus Core Select ETF
VanEck Morningstar Wide Moat Value ETF
iShares ESG Aware MSCI USA Value ETF
Macquarie Focused Large Growth ETF
Monarch Blue Chips Core ETF
Eagle Capital Select Equity ETF
iREIT MarketVector Quality REIT Index ETF
JPMorgan Healthcare Leaders ETF
FMC Excelsior Focus Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Parnassus Core Select ETF
āļŠāļąāļāļŠāđāļ§āļ6.32%
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļāļŠāđāļ§āļ4.47%
iShares ESG Aware MSCI USA Value ETF
āļŠāļąāļāļŠāđāļ§āļ3.95%
Macquarie Focused Large Growth ETF
āļŠāļąāļāļŠāđāļ§āļ3.91%
Monarch Blue Chips Core ETF
āļŠāļąāļāļŠāđāļ§āļ3.82%
Eagle Capital Select Equity ETF
āļŠāļąāļāļŠāđāļ§āļ3.63%
Madison Covered Call ETF
āļŠāļąāļāļŠāđāļ§āļ3.37%
iREIT MarketVector Quality REIT Index ETF
āļŠāļąāļāļŠāđāļ§āļ3.35%
JPMorgan Healthcare Leaders ETF
āļŠāļąāļāļŠāđāļ§āļ3.23%
FMC Excelsior Focus Equity ETF
āļŠāļąāļāļŠāđāļ§āļ3.13%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
3.15B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
DHR.NB Interim Cash Dividend of gross USD 0.4 paid on Apr 24, 2026 going ex on Mar 27, 2026
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Jan 30, 2026 going ex on Dec 26, 2025
DHR.NB Final Cash Dividend of gross USD 0.32 paid on Oct 31, 2025 going ex on Sep 26, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Jul 25, 2025 going ex on Jun 27, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Apr 25, 2025 going ex on Mar 28, 2025
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jan 31, 2025 going ex on Dec 27, 2024
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 25, 2024 going ex on Sep 27, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 26, 2024 going ex on Jun 28, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 26, 2024 going ex on Mar 27, 2024
DHR.NB Interim Cash Dividend of gross USD 0.24 paid on Jan 26, 2024 going ex on Dec 28, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ